Jaume Campdelacreu

1.7k total citations
37 papers, 974 citations indexed

About

Jaume Campdelacreu is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jaume Campdelacreu has authored 37 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 10 papers in Molecular Biology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jaume Campdelacreu's work include Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (7 papers) and Alzheimer's disease research and treatments (5 papers). Jaume Campdelacreu is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (15 papers), Neurological disorders and treatments (7 papers) and Alzheimer's disease research and treatments (5 papers). Jaume Campdelacreu collaborates with scholars based in Spain, Australia and Germany. Jaume Campdelacreu's co-authors include Eduardo Tolosa, Ramón Reñé, Katrin Beyer, Ana Gámez‐Valero, Ramiro Álvarez, Lourdes Ispierto, Francesc E. Borràs, Dolores Vilas, Serge Jaumà and Jordi Gascón‐Bayarri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Jaume Campdelacreu

35 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaume Campdelacreu Spain 16 530 299 247 193 128 37 974
Maurizio Facheris United States 21 617 1.2× 256 0.9× 166 0.7× 215 1.1× 115 0.9× 43 1.1k
Petra Yescas Mexico 19 334 0.6× 499 1.7× 143 0.6× 469 2.4× 111 0.9× 55 1.0k
Yaping Yan China 18 363 0.7× 257 0.9× 145 0.6× 286 1.5× 127 1.0× 59 814
Maiko Uemura Japan 18 489 0.9× 350 1.2× 436 1.8× 262 1.4× 464 3.6× 31 1.3k
Jane Cooper United Kingdom 12 140 0.3× 406 1.4× 420 1.7× 247 1.3× 186 1.5× 17 924
Jiali Pu China 17 319 0.6× 438 1.5× 156 0.6× 158 0.8× 167 1.3× 48 913
Katalin Majtényi Hungary 14 464 0.9× 402 1.3× 391 1.6× 236 1.2× 295 2.3× 26 1.2k
Martha Foiani United Kingdom 18 256 0.5× 312 1.0× 408 1.7× 153 0.8× 158 1.2× 23 855
Hisatomo Kowa Japan 16 308 0.6× 275 0.9× 353 1.4× 189 1.0× 140 1.1× 69 895
Sarah Mustafa United Kingdom 11 158 0.3× 286 1.0× 109 0.4× 183 0.9× 156 1.2× 16 942

Countries citing papers authored by Jaume Campdelacreu

Since Specialization
Citations

This map shows the geographic impact of Jaume Campdelacreu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Campdelacreu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Campdelacreu more than expected).

Fields of papers citing papers by Jaume Campdelacreu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Campdelacreu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Campdelacreu. The network helps show where Jaume Campdelacreu may publish in the future.

Co-authorship network of co-authors of Jaume Campdelacreu

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Campdelacreu. A scholar is included among the top collaborators of Jaume Campdelacreu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Campdelacreu. Jaume Campdelacreu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muñoz‐Vendrell, Albert, et al.. (2025). False nonresponders to anti‐calcitonin gene‐related peptide monoclonal antibodies: A real‐world analysis beyond migraine frequency reduction. Headache The Journal of Head and Face Pain. 66(1). 172–182.
2.
Hernández, Giselle Riquelme, et al.. (2024). Cognitive decline in adult-onset temporal lobe epilepsy: Insights from aetiology. Clinical Neurology and Neurosurgery. 237. 108159–108159. 3 indexed citations
3.
Gámez‐Valero, Ana, Jaume Campdelacreu, Dolores Vilas, et al.. (2021). Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease. Biomedicines. 9(9). 1272–1272. 13 indexed citations
4.
Urbizu, Aintzane, Jaume Campdelacreu, Dolores Vilas, et al.. (2021). Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease. International Journal of Molecular Sciences. 22(2). 725–725. 8 indexed citations
5.
Gámez‐Valero, Ana, Jaume Campdelacreu, Ramón Reñé, Katrin Beyer, & Francesc E. Borràs. (2019). Comprehensive proteomic profiling of plasma-derived Extracellular Vesicles from dementia with Lewy Bodies patients. Scientific Reports. 9(1). 13282–13282. 21 indexed citations
6.
Vilas, Dolores, Lourdes Ispierto, Ramiro Álvarez, et al.. (2015). Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers. Parkinsonism & Related Disorders. 21(10). 1170–1176. 28 indexed citations
7.
Gascón‐Bayarri, Jordi, Jaume Campdelacreu, Jordi Estela, & Ramón Reñé. (2015). Severe Hyperammonemia in Late-Onset Ornithine Transcarbamylase Deficiency Triggered by Steroid Administration. SHILAP Revista de lepidopterología. 2015. 1–3. 18 indexed citations
8.
Campdelacreu, Jaume. (2014). Parkinson's disease and Alzheimer disease: environmental risk factors. SHILAP Revista de lepidopterología. 29(9). 541–549. 80 indexed citations
9.
Dobson‐Stone, Carol, Marianne Hallupp, Clement T. Loy, et al.. (2013). C9ORF72 Repeat Expansion in Australian and Spanish Frontotemporal Dementia Patients. PLoS ONE. 8(2). e56899–e56899. 37 indexed citations
10.
Campdelacreu, Jaume. (2012). Enfermedad de Parkinson y enfermedad de Alzheimer: factores de riesgo ambientales. Neurología. 29(9). 541–549. 81 indexed citations
11.
Reñé, Ramón, et al.. (2012). Complex Visual Manifestations of Posterior Cortical Atrophy. Journal of Neuro-Ophthalmology. 32(4). 307–312. 10 indexed citations
12.
13.
Gascón‐Bayarri, Jordi, et al.. (2011). Encefalopatía de Wernicke en pacientes no alcohólicos: una serie de 8 casos. Neurología. 26(9). 540–547. 21 indexed citations
14.
Heras, M., et al.. (2010). Importancia del estudio electromiográfico en el diagnóstico del temblor ortostático. Neurología. 26(1). 53–55. 2 indexed citations
15.
Sánchez‐Castañeda, Cristina, Ramón Reñé, Blanca Ramı́rez-Ruiz, et al.. (2010). Frontal and associative visual areas related to visual hallucinations in dementia with Lewy bodies and Parkinson's disease with dementia. Movement Disorders. 25(5). 615–622. 93 indexed citations
16.
Reñé, R., et al.. (2009). Familial Creutzfeldt–Jakob disease with E200K mutation presenting with neurosensorial hypoacusis: Figure 1. BMJ Case Reports. 2009. bcr0620092006–bcr0620092006. 1 indexed citations
17.
Alentorn, Agustí, Antoni Palasí, Jaume Campdelacreu, et al.. (2009). Pelvic dyskinesia with an outstanding response to tetrabenazine. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33(5). 847–848. 3 indexed citations
18.
Ezquerra, Mario, Jaume Campdelacreu, Esteban Muñoz, Eduardo Tolosa, & M. J. Martí. (2005). A Novel Intronic Mutation in the DDP1 Gene in a Family With X-linked Dystonia-Deafness Syndrome. Archives of Neurology. 62(2). 306–306. 18 indexed citations
19.
Ezquerra, Mario, Jaume Campdelacreu, Esteban Muñoz, Rafael Oliva, & Eduardo Tolosa. (2004). Sequence analysis of tau 3'untranslated region and saitohin gene in sporadic progressive supranuclear palsy.. PubMed. 75(1). 155–7. 14 indexed citations
20.
Campdelacreu, Jaume, Hatice Kumru, Eduard Tolosa, Josep Valls‐Solé, & Antoni Benabarre. (2003). Progressive supranuclear palsy syndrome induced by clebopride. Movement Disorders. 19(4). 482–484. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurizio Facheris Breakdown of academic impact, for papers by Petra Yescas Breakdown of academic impact, for papers by Yaping Yan Breakdown of academic impact, for papers by Maiko Uemura Breakdown of academic impact, for papers by Jane Cooper Breakdown of academic impact, for papers by Jiali Pu Breakdown of academic impact, for papers by Katalin Majtényi Breakdown of academic impact, for papers by Martha Foiani Breakdown of academic impact, for papers by Hisatomo Kowa Breakdown of academic impact, for papers by Sarah Mustafa
Rankless by CCL
2026